Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Plenty of companies did well in 2020 despite market dynamics connected to the coronavirus pandemic. Here's one that should fare particularly well in 2021.

Forget Moderna! This Is a Stronger Coronavirus Stock

Lengthened and heightened vaccine season (COVID-19 + flu) paired with omni-channel expansion will drive foot traffic and double digit EPS growth acceleration. Unique moat expansion with Aetna merger and expansion of HealthHubs presents an industry-differentiated holistic healthcare solution.

CVS Health: A Unique Holistic Healthcare Opportunity

CVS Health is planning to give $250 bonuses to nearly 200,000 of its workers to reward them for the work they've done to address the COVID-19 pandemic. The almost $50 million in bonuses will go out beginning in January, a CVS spokesperson confirmed.

CVS Health is giving $250 pandemic bonuses to nearly 200,000 of its workers

We believe that CVS Health stock is a good buying opportunity at the present time. CVS stock trades near $70 currently and it is, in fact, down 6% from its pre-Covid high of $74 in February 2020 – just before the coronavirus pandemic hit the world.

Should You Buy CVS Health Stock At $70?

Walgreens

On Indeed, a job-posting site, the share of searches containing 'vaccine' jumped by 116% from Dec. 1 to Dec 7.

Walgreens is looking to fill 25,000 positions to help administer COVID-19 vaccine. CVS has created 10,000 vaccine-related roles

BioNTech SE

Moderna

Pfizer

How Soon Will COVID Vaccines Be Available After FDA Authorization?

Walmart

Major U.S. retailers CVS and Walmart are readying to begin distributing COVID-19 vaccines, according to published reports. CNBC reported that CVS is ready to begin doling out the vaccines to the most vulnerable populations within 24 to 48 hours of receiving them.

CVS, Walmart To Provide COVID Vaccinations

American Well Corporation

Global X Telemedicine & Digital Health ETF

Royal Philips

Teladoc

Expect telehealth stocks to continue trending upward even though Covid-19 is slowly but surely receding into the background. The post 5 Telehealth Stocks That Will Keep Growing Post-Quarantine appeared first on InvestorPlace.

5 Telehealth Stocks That Will Keep Growing Post-Quarantine

The government struck a deal in October with CVS and Walgreens to administer the coronavirus vaccinations to residents and staff at long-term care facilities across the country.

CVS Health CEO says it has 10,000 staffers ready to vaccinate seniors at nursing homes

Apple

Alibaba

Bristol-Myers

Farfetch

Morgan Stanley

Everyone is on the hunt for undervalued stocks. Keep in mind, even more highly valued stocks can be undervalued.

7 Undervalued Stocks to Buy Now

WOONSOCKET, R.I., Dec. 7, 2020 /PRNewswire/ -- CVS Health (NYSE: CVS) is reminding everyone that it's not too late to get a flu shot, as the country marks National Influenza Vaccination Week (Dec. 6 – 12). The flu shot is the most effective way to protect against the flu and is an...

CVS Health Reminds Everyone There is Still Time to Get a Flu Shot during National Influenza Vaccination Week

WOONSOCKET, R.I., Dec. 7, 2020 /PRNewswire/ -- CVS Health Corporation ("CVS Health", NYSE: CVS) announced today that it has commenced cash tender offers (each, a "Tender Offer" and collectively, the "Tender Offers") for (i) up to $1,500,000,000 aggregate principal amount (the "2023 Notes...

CVS Health Corporation Announces Cash Tender Offers for Certain Outstanding Notes

Since the start of the pandemic, CVS Health (CVS) is seeing more than 40% of all specialty orders being placed digitally.

CVS Health (CVS) 2021 Selling Season Strong, LTC Arm Suffers

CVS Health has broadened its search for healthcare workers to vaccinate Americans against Covid-19 with a plea to customers to help find thousands of pharmacists, nurses and pharmacy technicians to administer millions of vaccinations.

CVS Hiring Spree Includes Plea To ‘Help End The Pandemic'

CVS Health (CVS) reported earnings 30 days ago. What's next for the stock?

CVS Health (CVS) Up 21.3% Since Last Earnings Report: Can It Continue?

Aaron's

Aflac

Humana

Intel

Novo Nordisk

These 7 cheap stocks span industry and have a great chance to appreciate in price next year. Click here for the metrics and reasoning.

7 Cheap Stocks to Buy for 2021 That Deserve Recognition

ACADIA Pharma

Healthcare Realty Trust Inc

uniQure

The health care sector as a whole has been a top performer this year, and there is every reason to believe that strong performance will carry through to 2021.

Raymond James Top Health Care Picks Crushing S&P 500: 4 Stocks to Buy Now

The nation's two largest drugstore operators are about to get a much-needed shot in the arm -- while giving out millions of them for free.

The COVID Vaccine Rollout Will Be a Boon for These 2 Beaten-Down Stocks

Century Casinos

Johnson & Johnson

Kohl's

Altria

Wynn Resorts

There aren't many undervalued stocks out there, but some familiar, quality names fit the bill. We've pulled that list together for you.

7 Undervalued Stocks to Snap Up Today

HONOLULU, Dec. 2, 2020 /PRNewswire/ -- Longs Drugs and its parent company CVS Health (NYSE: CVS) today held a community grand opening ceremony and blessing to debut HealthHUB, a new store format at three store locations in Hawaii. The innovative health care experience enables individuals...

Longs Drugs Debuts HealthHUB Experience to Serve Hawaii

This retail pharmacy stock is dirt cheap. But don't be fooled.

What's the Outlook for CVS Health Stock?

AutoZone

Intercontinental Exchange

Jabil

Kansas City Southern

All the firms we follow here at 24/7 Wall St. keep a list for their institutional and retail clients of high-conviction stock picks.

5 Raymond James Favorite Blue-Chip Stocks to Buy That Could Soar in 2021

These healthcare stocks can deliver steady growth in the coming decade as demographics suggest tailwinds for the industry. The post 4 Healthcare Stocks That Will Take Care of You appeared first on InvestorPlace.

4 Healthcare Stocks That Will Take Care of You

WOONSOCKET, R.I., Nov. 30, 2020 /PRNewswire/ -- CVS Health Corporation (NYSE: CVS) today announced that Larry Merlo, President and Chief Executive Officer; and Eva Boratto, Executive Vice President and Chief Financial Officer; and Karen Lynch, Executive Vice President and President of...

CVS Health to Present at the Evercore ISI 3rd Annual HealthCONx 2020

AbbVie

Citigroup

Citizens Financial Group

Chevron

Enterprise Products Partners

Exelon

Diamondback Energy

Marathon Petroleum

NRG Energy

Realty Income Corp

Phillips 66

Valero Energy

In October and July, Kiplinger Today listed Analyst and Kiplinger favorite dividend stocks. Analyst October favorites numbered 25, plus 15 from Kiplinger, with one repeated left 39 total. These 39 stocks ranged from 1.42% to 8.74% in annual yield and ranged from 0.13% to 33.33% in one-year price target upsides per brokers 11/25/20.

News for CVS Health Stock (CVS)